FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to new compounds able to prevent the extracellular release of inflammatory cytokines. Proposed compounds including their diastereomeric forms and their pharmaceutically acceptable salts correspond to the formula: wherein R means: (a) -O[CH2]kR3 or (b) -NR4aR4b; R3 means a substituted or unsubstituted (C1-C4)-alkyl, a substituted or unsubstituted phenyl wherein substitutes are taken among halogen atom, cyano-group, trihalidemethyl, (C1-C4)-alkyl, (C1-C4)-alkylsulfonyl, -NR4aR4b, -O[CH2]kR3 wherein R3 means hydrogen atom each among R4a and R4b means independently hydrogen atom or (C1-C4)-alkyl-CO- or benzo(1,3)dioxol; index k has a value from 0 to 5; each among R4a and R4b means independently: (a) hydrogen atom or (b) -[C(R5aR5b)2]mR6 wherein each Ra means hydrogen atom, and R5b means hydrogen atom, linear or branched (C1-C)-alkyl; R6 means vinyl, the group -OR7, -CO2R7, cyclic (C3-C)-alkyl, unsubstituted phenyl or phenyl substituted with (C1-C4)-alkyl, (C1-C4)-alkylsulfonyl, -NR4aR4b, -O[CH2]kR3 wherein each among R3, R4a and R4b means independently hydrogen atom, or unsubstituted 6-membered nitrogen-containing heteroaryl; R7 means hydrogen atom, water-soluble cation or (C1-C4)-alkyl; index m has a value from 0 to 5. Also, invention relates to a pharmaceutical composition comprising the effective dose of compounds corresponding to abovementioned formula, and to a method for inhibition of extracellular release of inflammatory cytokines.
EFFECT: valuable medicinal properties of compounds and composition.
14 cl, 1 sch, 6 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
6,7-DIHYDRO-5H-PYRAZOLO[1,2-a]PYRAZOLE-1-ONES (VARIANTS) INHIBITING RELEASE OF INFLAMMATORY CYTOKINES, PHARMACEUTICAL COMPOSITION AND INHIBITION METHOD | 2002 |
|
RU2299885C2 |
6,7-DIHYDRO-5H-PYRAZOLO[1,2-A]PYRAZOL-1-ONES REGULATING INFLAMMATORY CYTOKINES, (VARIANTS) AND PHARMACEUTICAL COMPOSITION | 2003 |
|
RU2289584C2 |
BICYCLIC PYRAZOLON INHIBITORS OF CYTOKINES | 2004 |
|
RU2358976C2 |
COMPOUNDS THAT INHIBIT RELEASING INFLAMMATORY CYTOKINES | 2002 |
|
RU2278864C2 |
SUBSTITUTED 1,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONES | 2019 |
|
RU2812726C2 |
COMPOUND BASED ON DIHYDRONAPTHYRIDINONE, METHOD OF ITS OBTAINING, AND ITS USE IN MEDICINE | 2021 |
|
RU2809869C1 |
CONDENSED PYRIDINE DERIVATIVES APPLICABLE AS ANTAGONISTS OF ADENOSINE RECEPTOR A | 2005 |
|
RU2370496C2 |
COMPOUNDS 6,7-DIHYDRO-5H-PYRAZOLO[5,1-B][1,3]OXAZINE-2-CARBOXAMIDE | 2017 |
|
RU2719599C2 |
SUBSTITUTED PYRAZOLOPYRIMIDINES AS GLUCOCEREBROSIDASE ACTIVATORS | 2011 |
|
RU2603637C2 |
METHOD FOR PREDICTABLE COLOURING OF KERATIN FIBRES BY DEPOSITING COMPOSITION, CONTAINING DERIVATIVE OF DIAMINO-N, N-DIHYDROPYRAZOLONE, AND MAIN COMPOSITION OR YELLOW COMPOSITION | 2007 |
|
RU2363444C2 |
Authors
Dates
2006-03-20—Published
2002-09-20—Filed